| 2025/0114,406 | METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS | Jan 04, 24 | Apr 10, 25 | Not available |
| 2025/0114,421 | METHOD FOR IMPROVING HEALTH CONDITION OF MAMMAL OR FARM ANIMAL | Apr 27, 23 | Apr 10, 25 | Not available |
| 2025/0108,072 | NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAME | Sep 10, 24 | Apr 03, 25 | Not available |
| 2025/0108,128 | CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS | Jan 25, 23 | Apr 03, 25 | Not available |
| 2025/0099,473 | TREATMENT OF MITOCHONDRIAL DISEASES | May 01, 24 | Mar 27, 25 | Not available |
| 2025/0101,401 | ENGINEERED METHIONINE GAMMA LYASE VARIANTS | Sep 05, 24 | Mar 27, 25 | Not available |
| 2025/0090,526 | METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR | Apr 22, 24 | Mar 20, 25 | Not available |
| 2025/0073,181 | REDUCTION OF ADIPOSE TISSUE | Sep 30, 24 | Mar 06, 25 | Not available |
| 2025/0073,210 | Use of Ergothioneine for Enhancing Glutathione Level | Dec 30, 22 | Mar 06, 25 | Not available |
| 2025/0066,454 | COMPLEX COACERVATES OF LACTOFERRIN AND OSTEOPONTIN | Dec 16, 22 | Feb 27, 25 | Not available |
| 2025/0059,257 | PREPARATION METHOD AND APPLICATION OF HIGH-PURITY PLANT-DERIVED RECOMBINANT HUMAN SERUM ALBUMIN | Oct 23, 24 | Feb 20, 25 | Not available |
| 2025/0049,952 | IMPROVED GENE THERAPY CONSTRUCTS FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA | Dec 29, 22 | Feb 13, 25 | The United States of America as represented by the Secretary Department of Health and Human Services |
| 2025/0051,740 | TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS | May 09, 24 | Feb 13, 25 | REGENXBIO Inc. |
| 2025/0051,780 | COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICING | May 09, 22 | Feb 13, 25 | Not available |
| 2025/0041,445 | GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA | Nov 11, 22 | Feb 06, 25 | The Trustees of the University of Pennsylvania; Amicus Therapeutics, Inc.; |
| 2025/0041,455 | ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DISEASE | Jul 26, 24 | Feb 06, 25 | Not available |
| 2025/0043,261 | METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS | Jul 11, 24 | Feb 06, 25 | Not available |
| 2025/0043,285 | Mammalian ATG8 Proteins and ATG9A Direct Sealing of Autophagosomal Membranes | Jul 02, 24 | Feb 06, 25 | Not available |
| 2025/0043,000 | NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF | Aug 21, 24 | Feb 06, 25 | The National Institute for Biotechnology in the Negev Ltd. |
| 2025/0032,642 | CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS | Feb 02, 23 | Jan 30, 25 | Not available |